Ultimately, harnessing the gutkidney axis for therapy requires integrated immunometabolic strategies, offering hope for slowing CKD progression in millions of patients
Spaan N, Teplova A, Stam G, Spaan J, Lucas C (2014) Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus
"While its ultimately up to patients to choose the pharmacy they prefer, we have maintained a track record of dispensing GLP-1 medications since 2021, and will continue to expand access to new and emerging weight management medications including Eli Lilly and Company's Zepbound auto-injector and KwikPen, its new Foundayo pill, and Novo Nordisk's Wegovy pill and injectables." One Medical clinicians work with patients to send prescriptions to the pharmacy of their choice
The glucose-dependence that makes them safe, the central action that drives weight loss, the cardiovascular and renal benefits, and the gastrointestinal side effects all trace back to where the receptor sits and how it signals